{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T21:31:01Z","timestamp":1792963861174,"version":"4.5.0"},"reference-count":155,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T00:00:00Z","timestamp":1764720000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Minufiya University"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Med"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Cigarette smoking, a leading cause of preventable morbidity and mortality worldwide, has increasingly been recognized as a significant and independent risk factor for the development and progression of various liver diseases. Historically, the direct impact of smoking on liver health received limited attention compared to its well-established effects on the respiratory and cardiovascular systems. However, a growing body of evidence now unequivocally demonstrates that smoking negatively influences the incidence, severity, and outcomes of a wide spectrum of hepatic conditions, including metabolic dysfunction-associated steatotic liver disease (MASLD), alcohol-related liver disease (ALD), chronic viral hepatitis (HBV and HCV), primary biliary cholangitis (PBC), and hepatocellular carcinoma (HCC). The detrimental effects of tobacco extend to patients undergoing liver transplantation, where smoking is associated with increased post-transplant complications and mortality. The underlying mechanisms are complex, involving direct and indirect toxic effects, immunologic dysregulation, and oncogenic pathways, primarily driven by oxidative stress, systemic inflammation, insulin resistance, and the presence of numerous carcinogens in tobacco smoke. This comprehensive review synthesizes current knowledge, highlighting the multifaceted ways in which smoking impacts liver health, from cellular injury and fibrosis progression to increased cancer risk and compromised transplant outcomes. In addition, we explore the rising prevalence of electronic cigarette use and present the latest evidence regarding their potential impact on liver health. We emphasize the critical importance of smoking cessation as a therapeutic intervention across all stages of liver disease and discuss the challenges and strategies for its implementation. By integrating the updated research data and clinical insights, this review aims to underscore the urgent need for greater awareness among healthcare professionals and patients regarding the profound and pervasive link between smoking and liver disease, advocating for targeted interventions to alleviate this preventable burden.<\/jats:p>","DOI":"10.1007\/s10238-025-01922-6","type":"journal-article","created":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T04:58:40Z","timestamp":1764737920000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Smoking and liver diseases: an updated review of pathogenesis, progression, and therapeutic implications"],"prefix":"10.1007","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6776-1371","authenticated-orcid":false,"given":"Gasser","family":"El-Azab","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehab","family":"Elkhouly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rania","family":"Abouyoussef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanaa","family":"Nagdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,3]]},"reference":[{"issue":"2","key":"1922_CR1","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1136\/tobaccocontrol-2021-056535","volume":"31","author":"X Dai","year":"2022","unstructured":"Dai X, Gakidou E, Lopez AD. Evolution of the global smoking epidemic over the past half century: strengthening the evidence base for policy action. Tob Control. 2022;31(2):129\u201337.","journal-title":"Tob Control"},{"issue":"12","key":"1922_CR2","first-page":"617","volume":"16","author":"SM Rutledge","year":"2020","unstructured":"Rutledge SM, Asgharpour A. Smoking and liver disease. Gastroenterol Hepatol (N Y). 2020;16(12):617\u201325.","journal-title":"Gastroenterol Hepatol (N Y)"},{"issue":"1","key":"1922_CR3","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.jhep.2022.01.016","volume":"77","author":"D Marti-Aguado","year":"2022","unstructured":"Marti-Aguado D, Clemente-Sanchez A, Bataller R. Cigarette smoking and liver diseases. J Hepatol. 2022;77(1):191\u2013205.","journal-title":"J Hepatol"},{"issue":"6","key":"1922_CR4","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1016\/j.jceh.2021.07.016","volume":"11","author":"M Premkumar","year":"2021","unstructured":"Premkumar M, Anand AC. Tobacco, cigarettes, and the liver: the smoking gun. J Clin Exp Hepatol. 2021;11(6):700\u201312.","journal-title":"J Clin Exp Hepatol"},{"key":"1922_CR5","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/j.toxrep.2023.02.005","volume":"10","author":"T Hashizume","year":"2023","unstructured":"Hashizume T, Ishikawa S, Matsumura K, Ito S, Fukushima T. Chemical and in vitro toxicological comparison of emissions from a heated tobacco product and the 1R6F reference cigarette. Toxicol Rep. 2023;10:281\u201392.","journal-title":"Toxicol Rep"},{"issue":"1","key":"1922_CR6","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1186\/s12967-024-05688-5","volume":"22","author":"A Distefano","year":"2024","unstructured":"Distefano A, Orlando L, Partsinevelos K, Longhitano L, Emma R, Caruso M, et al. Comparative evaluation of cigarette smoke and a heated tobacco product on microglial toxicity, oxidative stress and inflammatory response. J Transl Med. 2024;22(1):876.","journal-title":"J Transl Med"},{"key":"1922_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.18332\/tpc\/115062","volume":"6","author":"AC Koregol","year":"2020","unstructured":"Koregol AC, Kalburgi NB, Pattanashetty P, Warad S, Shirigeri NS, Hunasikatti VC. Effect of smokeless tobacco use on salivary glutathione levels among chronic periodontitis patients before and after non-surgical periodontal therapy. Tob Prev Cessat. 2020;6:15.","journal-title":"Tob Prev Cessat"},{"key":"1922_CR8","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000300","author":"O Balogun","year":"2023","unstructured":"Balogun O, Wang JY, Shaikh ES, Liu K, Stoyanova S, Memel ZN, et al. Effect of combined tobacco use and type 2 diabetes mellitus on prevalent fibrosis in patients with MASLD. Hepatol Commun. 2023. https:\/\/doi.org\/10.1097\/HC9.0000000000000300.","journal-title":"Hepatol Commun"},{"issue":"12","key":"1922_CR9","doi-asserted-by":"publisher","first-page":"4803","DOI":"10.7314\/APJCP.2015.16.12.4803","volume":"16","author":"AA Mansoori","year":"2015","unstructured":"Mansoori AA, Jain SK. Molecular links between alcohol and tobacco induced DNA damage, gene polymorphisms and patho-physiological consequences: a systematic review of hepatic carcinogenesis. Asian Pac J Cancer Prev. 2015;16(12):4803\u201312.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"12","key":"1922_CR10","doi-asserted-by":"publisher","first-page":"1461","DOI":"10.1097\/MEG.0000000000001234","volume":"30","author":"A Mantaka","year":"2018","unstructured":"Mantaka A, Koulentaki M, Samonakis D, Sifaki-Pistolla D, Voumvouraki A, Tzardi M, et al. Association of smoking with liver fibrosis and mortality in primary biliary cholangitis. Eur J Gastroenterol Hepatol. 2018;30(12):1461\u20139.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"226","key":"1922_CR11","first-page":"e1","volume":"55","author":"H Anaqrah","year":"2022","unstructured":"Anaqrah H, McCabe DJ. Severe chronic Carboxyhemoglobinemia and polycythemia due to smoking hookah. Am J Emerg Med. 2022;55(226):e1\u20132.","journal-title":"Am J Emerg Med"},{"issue":"1","key":"1922_CR12","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.sjbs.2019.11.001","volume":"27","author":"AQ Alkhedaide","year":"2020","unstructured":"Alkhedaide AQ. Tobacco smoking causes secondary polycythemia and a mild leukocytosis among heavy smokers in Taif City in Saudi Arabia. Saudi J Biol Sci. 2020;27(1):407\u201311.","journal-title":"Saudi J Biol Sci"},{"issue":"3","key":"1922_CR13","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1097\/MOH.0000000000000494","volume":"26","author":"C Renassia","year":"2019","unstructured":"Renassia C, Peyssonnaux C. New insights into the links between hypoxia and iron homeostasis. Curr Opin Hematol. 2019;26(3):125\u201330.","journal-title":"Curr Opin Hematol"},{"issue":"4","key":"1922_CR14","doi-asserted-by":"publisher","first-page":"3738","DOI":"10.1021\/acsomega.1c06476","volume":"7","author":"Q Xu","year":"2022","unstructured":"Xu Q, Xia W, Zhou L, Zou Z, Li Q, Deng L, et al. Determination of hepatic iron deposition in drug-induced liver fibrosis in rats by confocal micro-XRF spectrometry. ACS Omega. 2022;7(4):3738\u201345.","journal-title":"ACS Omega"},{"issue":"14","key":"1922_CR15","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3748\/wjg.v13.i14.2061","volume":"13","author":"JY He","year":"2007","unstructured":"He JY, Ge WH, Chen Y. Iron deposition and fat accumulation in dimethylnitrosamine-induced liver fibrosis in rat. World J Gastroenterol. 2007;13(14):2061\u20135.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"1922_CR16","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1016\/j.cgh.2006.03.019","volume":"4","author":"A Dev","year":"2006","unstructured":"Dev A, Patel K, Conrad A, Blatt LM, McHutchison JG. Relationship of smoking and fibrosis in patients with chronic hepatitis C. Clin Gastroenterol Hepatol. 2006;4(6):797\u2013801.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"1922_CR17","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0950-3536(89)80017-4","volume":"2","author":"JM Gutteridge","year":"1989","unstructured":"Gutteridge JM, Halliwell B. Iron toxicity and oxygen radicals. Baillieres Clin Haematol. 1989;2(2):195\u2013256.","journal-title":"Baillieres Clin Haematol"},{"issue":"1","key":"1922_CR18","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.vph.2006.06.006","volume":"46","author":"MM Rahman","year":"2007","unstructured":"Rahman MM, Elmi S, Chang TK, Bai N, Sallam NA, Lemos VS, et al. Increased vascular contractility in isolated vessels from cigarette smoking rats is mediated by basal endothelin release. Vascul Pharmacol. 2007;46(1):35\u201342.","journal-title":"Vascul Pharmacol"},{"issue":"11","key":"1922_CR19","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1007\/s00011-008-8078-6","volume":"57","author":"H Mehta","year":"2008","unstructured":"Mehta H, Nazzal K, Sadikot RT. Cigarette smoking and innate immunity. Inflamm Res. 2008;57(11):497\u2013503.","journal-title":"Inflamm Res"},{"issue":"3","key":"1922_CR20","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/S0378-4274(00)00270-8","volume":"118","author":"P Moszczynski","year":"2001","unstructured":"Moszczynski P, Zabinski Z, Moszczynski P Jr, Rutowski J, Slowinski S, Tabarowski Z. Immunological findings in cigarette smokers. Toxicol Lett. 2001;118(3):121\u20137.","journal-title":"Toxicol Lett"},{"issue":"8000","key":"1922_CR21","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/s41586-023-06968-8","volume":"626","author":"V Saint-Andre","year":"2024","unstructured":"Saint-Andre V, Charbit B, Biton A, Rouilly V, Posseme C, Bertrand A, et al. Smoking changes adaptive immunity with persistent effects. Nature. 2024;626(8000):827\u201335.","journal-title":"Nature"},{"issue":"Suppl 1","key":"1922_CR22","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.21037\/tlcr.2019.03.02","volume":"8","author":"NH Yamaguchi","year":"2019","unstructured":"Yamaguchi NH. Smoking, immunity, and DNA damage. Transl Lung Cancer Res. 2019;8(Suppl 1):S3\u20136.","journal-title":"Transl Lung Cancer Res"},{"key":"1922_CR23","doi-asserted-by":"publisher","first-page":"122730","DOI":"10.1016\/j.envpol.2023.122730","volume":"339","author":"Y Liu","year":"2023","unstructured":"Liu Y, Lu L, Yang H, Wu X, Luo X, Shen J, et al. Dysregulation of immunity by cigarette smoking promotes inflammation and cancer: a review. Environ Pollut. 2023;339:122730.","journal-title":"Environ Pollut"},{"issue":"8","key":"1922_CR24","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1034\/j.1399-6576.2002.460806.x","volume":"46","author":"A Zeidel","year":"2002","unstructured":"Zeidel A, Beilin B, Yardeni I, Mayburd E, Smirnov G, Bessler H. Immune response in asymptomatic smokers. Acta Anaesthesiol Scand. 2002;46(8):959\u201364.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"1","key":"1922_CR25","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1006\/cimm.1998.1432","volume":"192","author":"N Suzuki","year":"1999","unstructured":"Suzuki N, Wakisaka S, Takeba Y, Mihara S, Sakane T. Effects of cigarette smoking on Fas\/Fas ligand expression of human lymphocytes. Cell Immunol. 1999;192(1):48\u201353.","journal-title":"Cell Immunol"},{"issue":"2","key":"1922_CR26","doi-asserted-by":"publisher","first-page":"zcad015","DOI":"10.1093\/narcan\/zcad015","volume":"5","author":"AL Armijo","year":"2023","unstructured":"Armijo AL, Thongararm P, Fedeles BI, Yau J, Kay JE, Corrigan JJ, et al. Molecular origins of mutational spectra produced by the environmental carcinogen N-nitrosodimethylamine and S(N)1 chemotherapeutic agents. NAR Cancer. 2023;5(2):zcad015.","journal-title":"NAR Cancer"},{"issue":"3","key":"1922_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1093\/oxfordjournals.aje.a009452","volume":"147","author":"LY Wang","year":"1998","unstructured":"Wang LY, Chen CJ, Zhang YJ, Tsai WY, Lee PH, Feitelson MA, et al. 4-aminobiphenyl DNA damage in liver tissue of hepatocellular carcinoma patients and controls. Am J Epidemiol. 1998;147(3):315\u201323.","journal-title":"Am J Epidemiol"},{"issue":"1","key":"1922_CR28","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1002\/ajim.22922","volume":"62","author":"U Fedeli","year":"2019","unstructured":"Fedeli U, Girardi P, Gardiman G, Zara D, Scoizzato L, Ballarin MN, et al. Mortality from liver angiosarcoma, hepatocellular carcinoma, and cirrhosis among vinyl chloride workers. Am J Ind Med. 2019;62(1):14\u201320.","journal-title":"Am J Ind Med"},{"key":"1922_CR29","doi-asserted-by":"publisher","first-page":"118431","DOI":"10.1016\/j.ecoenv.2025.118431","volume":"300","author":"Y Li","year":"2025","unstructured":"Li Y, Jian Y, Zhou J, Zhang M, Zhou Y, Ge Y, et al. Molecular regulatory networks of microplastics and cadmium mediated hepatotoxicity from NAFLD to tumorigenesis via integrated approaches. Ecotoxicol Environ Saf. 2025;300:118431.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"9","key":"1922_CR30","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.3390\/nu16091309","volume":"16","author":"R Derkacz","year":"2024","unstructured":"Derkacz R, Marciniak W, Baszuk P, Wysokinska M, Chrzanowska N, Lener M, et al. Blood cadmium level is a marker of cancer risk in men. Nutrients. 2024;16(9):1309.","journal-title":"Nutrients"},{"issue":"4","key":"1922_CR31","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1002\/tox.23731","volume":"38","author":"S Niture","year":"2023","unstructured":"Niture S, Gadi S, Lin M, Qi Q, Niture SS, Moore JT, et al. Cadmium modulates steatosis, fibrosis, and oncogenic signaling in liver cancer cells by activating notch and AKT\/mTOR pathways. Environ Toxicol. 2023;38(4):783\u201397.","journal-title":"Environ Toxicol"},{"key":"1922_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines10123202","author":"D Tumen","year":"2022","unstructured":"Tumen D, Heumann P, Gulow K, Demirci CN, Cosma LS, Muller M, et al. Pathogenesis and current treatment strategies of hepatocellular carcinoma. Biomedicines. 2022. https:\/\/doi.org\/10.3390\/biomedicines10123202.","journal-title":"Biomedicines"},{"key":"1922_CR33","doi-asserted-by":"publisher","DOI":"10.1097\/HC9.0000000000000627","author":"D Rayapati","year":"2025","unstructured":"Rayapati D, McGlynn KA, Groopman JD, Kim AK. Environmental exposures and the risk of hepatocellular carcinoma. Hepatol Commun. 2025. https:\/\/doi.org\/10.1097\/HC9.0000000000000627.","journal-title":"Hepatol Commun"},{"issue":"3\u20134","key":"1922_CR34","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1159\/000516598","volume":"24","author":"H Wang","year":"2021","unstructured":"Wang H, Chen L, Zhou T, Zhang Z, Zeng C. P53 mutation at serine 249 and its gain of function are highly related to hepatocellular carcinoma after smoking exposure. Public Health Genom. 2021;24(3\u20134):171\u201381.","journal-title":"Public Health Genom"},{"key":"1922_CR35","doi-asserted-by":"publisher","first-page":"115952","DOI":"10.1016\/j.ecoenv.2024.115952","volume":"271","author":"J Li","year":"2024","unstructured":"Li J, Tuo D, Cheng T, Deng Z, Gan J. Gcf2 mediates nicotine-induced cancer stemness and progression in hepatocellular carcinoma. Ecotoxicol Environ Saf. 2024;271:115952.","journal-title":"Ecotoxicol Environ Saf"},{"issue":"Pt 1","key":"1922_CR36","doi-asserted-by":"publisher","first-page":"117256","DOI":"10.1016\/j.bcp.2025.117256","volume":"242","author":"Z Li","year":"2025","unstructured":"Li Z, Ding H, Hu Y, Zhang Z, Wang H. The dual role of nicotine in the development and progression of hepatocellular carcinoma. Biochem Pharmacol. 2025;242(Pt 1):117256.","journal-title":"Biochem Pharmacol"},{"key":"1922_CR37","doi-asserted-by":"publisher","first-page":"153924","DOI":"10.1016\/j.tox.2024.153924","volume":"508","author":"Y Xu","year":"2024","unstructured":"Xu Y, He Z, Rao Z, Li Z, Hu Y, Zhang Z, et al. The role of beta2-AR\/PI3K\/AKT pathway in the proliferation, migration and invasion of THLE-2 cells induced by nicotine. Toxicology. 2024;508:153924.","journal-title":"Toxicology"},{"issue":"4","key":"1922_CR38","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1177\/0022034512438402","volume":"91","author":"CJ Weng","year":"2012","unstructured":"Weng CJ, Hsieh YH, Chen MK, Tsai CM, Lin CW, Yang SF. Survivin SNP-carcinogen interactions in oral cancer. J Dent Res. 2012;91(4):358\u201363.","journal-title":"J Dent Res"},{"issue":"3","key":"1922_CR39","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1006\/jmbi.2001.4997","volume":"313","author":"JF Cloutier","year":"2001","unstructured":"Cloutier JF, Drouin R, Weinfeld M, O\u2019Connor TR, Castonguay A. Characterization and mapping of DNA damage induced by reactive metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) at nucleotide resolution in human genomic DNA. J Mol Biol. 2001;313(3):539\u201357.","journal-title":"J Mol Biol"},{"issue":"100","key":"1922_CR40","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.gde.2013.11.014","volume":"24","author":"LB Alexandrov","year":"2014","unstructured":"Alexandrov LB, Stratton MR. Mutational signatures: the patterns of somatic mutations hidden in cancer genomes. Curr Opin Genet Dev. 2014;24(100):52\u201360.","journal-title":"Curr Opin Genet Dev"},{"issue":"1","key":"1922_CR41","doi-asserted-by":"publisher","first-page":"18382","DOI":"10.1038\/s41598-023-45716-w","volume":"13","author":"WR Seif Eldin","year":"2023","unstructured":"Seif Eldin WR, Saad EA, Monier A, Elshazli RM. Association of TERT (rs2736098 and rs2736100) genetic variants with elevated risk of hepatocellular carcinoma: a retrospective case-control study. Sci Rep. 2023;13(1):18382.","journal-title":"Sci Rep"},{"issue":"12","key":"1922_CR42","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1631\/jzus.B2100201","volume":"22","author":"A Zepeda-Bastida","year":"2021","unstructured":"Zepeda-Bastida A, Ocampo-Lopez J, Alarcon-Sanchez BR, Idelfonso-Garcia OG, Rosas-Madrigal S, Aparicio-Bautista DI, et al. Aqueous extracts from Tenebrio molitor larval and pupal stages inhibit early hepatocarcinogenesis in vivo. J Zhejiang Univ Sci B. 2021;22(12):1045\u201352.","journal-title":"J Zhejiang Univ Sci B"},{"key":"1922_CR43","doi-asserted-by":"publisher","DOI":"10.1111\/hepr.14240","author":"B Askeyev","year":"2025","unstructured":"Askeyev B, Soyama A, Miyamoto D, Hasegawa K, Matsushima H, Hara T, et al. Investigation of possible telomerase reverse transcriptase promoter mutation in human chemically induced liver progenitors. Hepatol Res. 2025. https:\/\/doi.org\/10.1111\/hepr.14240.","journal-title":"Hepatol Res"},{"issue":"1","key":"1922_CR44","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1016\/j.canlet.2008.05.036","volume":"271","author":"T Sakamoto","year":"2008","unstructured":"Sakamoto T, Higaki Y, Hara M, Ichiba M, Horita M, Mizuta T, et al. Interaction between interleukin-1beta -31T\/C gene polymorphism and drinking and smoking habits on the risk of hepatocellular carcinoma among Japanese. Cancer Lett. 2008;271(1):98\u2013104.","journal-title":"Cancer Lett"},{"issue":"3","key":"1922_CR45","doi-asserted-by":"publisher","first-page":"J258","DOI":"10.1016\/j.jaut.2009.12.003","volume":"34","author":"Y Arnson","year":"2010","unstructured":"Arnson Y, Shoenfeld Y, Amital H. Effects of tobacco smoke on immunity, inflammation and autoimmunity. J Autoimmun. 2010;34(3):J258\u201365.","journal-title":"J Autoimmun"},{"issue":"4","key":"1922_CR46","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1093\/ajcn\/87.4.801","volume":"87","author":"A Chiolero","year":"2008","unstructured":"Chiolero A, Faeh D, Paccaud F, Cornuz J. Consequences of smoking for body weight, body fat distribution, and insulin resistance. Am J Clin Nutr. 2008;87(4):801\u20139.","journal-title":"Am J Clin Nutr"},{"issue":"5","key":"1922_CR47","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1097\/WON.0000000000000057","volume":"41","author":"JC McDaniel","year":"2014","unstructured":"McDaniel JC, Browning KK. Smoking, chronic wound healing, and implications for evidence-based practice. J Wound Ostomy Continence Nurs. 2014;41(5):415\u201323 (quiz E1-2).","journal-title":"J Wound Ostomy Continence Nurs"},{"issue":"1","key":"1922_CR48","doi-asserted-by":"publisher","first-page":"5","DOI":"10.12968\/jowc.2010.19.1.46092","volume":"19","author":"J Kean","year":"2010","unstructured":"Kean J. The effects of smoking on the wound healing process. J Wound Care. 2010;19(1):5\u20138.","journal-title":"J Wound Care"},{"issue":"9","key":"1922_CR49","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1111\/apt.70020","volume":"61","author":"ZM Younossi","year":"2025","unstructured":"Younossi ZM, Razavi H, Sherman M, Allen AM, Anstee QM, Cusi K, et al. Addressing the high and rising global burden of metabolic dysfunction-associated steatotic liver disease (MASLD) and metabolic dysfunction-associated steatohepatitis (MASH): from the growing prevalence to payors\u2019 perspective. Aliment Pharmacol Ther. 2025;61(9):1467\u201378.","journal-title":"Aliment Pharmacol Ther"},{"issue":"15","key":"1922_CR50","doi-asserted-by":"publisher","first-page":"e34915","DOI":"10.1016\/j.heliyon.2024.e34915","volume":"10","author":"I Ergenc","year":"2024","unstructured":"Ergenc I, Kara E, Yilmaz ME, Demirtas CO, Keklikkiran C, Das T, et al. Prevalence of metabolic dysfunction-associated steatotic liver disease and steatohepatitis in Turkiye: a forensic autopsy study. Heliyon. 2024;10(15):e34915.","journal-title":"Heliyon"},{"issue":"4","key":"1922_CR51","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/liv.15852","volume":"44","author":"ZM Younossi","year":"2024","unstructured":"Younossi ZM, Golabi P, Paik J, Owrangi S, Yilmaz Y, El-Kassas M, et al. Prevalence of metabolic dysfunction-associated steatotic liver disease in the Middle East and North Africa. Liver Int. 2024;44(4):1061\u201370.","journal-title":"Liver Int"},{"issue":"6","key":"1922_CR52","doi-asserted-by":"publisher","first-page":"e0325305","DOI":"10.1371\/journal.pone.0325305","volume":"20","author":"H Joe","year":"2025","unstructured":"Joe H, Oh JE, Cho YJ, Shin HS. Association between smoking status and non-alcoholic fatty liver disease. PLoS ONE. 2025;20(6):e0325305.","journal-title":"PLoS ONE"},{"issue":"1","key":"1922_CR53","doi-asserted-by":"publisher","first-page":"113","DOI":"10.14218\/JCTH.2023.00165","volume":"12","author":"X Ge","year":"2024","unstructured":"Ge X, Lu J, Yu C, Guo W, Tian T, Xu X, et al. Associations between active, passive smoking and the risk of nonalcoholic fatty liver disease. J Clin Transl Hepatol. 2024;12(1):113\u20138.","journal-title":"J Clin Transl Hepatol"},{"issue":"3","key":"1922_CR54","first-page":"E102","volume":"66","author":"H Takenaka","year":"2020","unstructured":"Takenaka H, Fujita T, Masuda A, Yano Y, Watanabe A, Kodama Y. Non-alcoholic fatty liver disease is strongly associated with smoking status and is improved by smoking cessation in Japanese males: a retrospective study. Kobe J Med Sci. 2020;66(3):E102\u201312.","journal-title":"Kobe J Med Sci"},{"issue":"1","key":"1922_CR55","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1136\/jim-2016-000213","volume":"65","author":"H Shen","year":"2017","unstructured":"Shen H, Peng JL, Tayarachakul S, Liangpunsakul S. Association between serum cotinine level and prevalence of non-alcoholic fatty liver disease: a cross-sectional study from the third national health and nutrition examination survey. J Investig Med. 2017;65(1):43\u20138.","journal-title":"J Investig Med"},{"issue":"2","key":"1922_CR56","doi-asserted-by":"publisher","first-page":"115","DOI":"10.2188\/jea.JE20120067","volume":"23","author":"Y Liu","year":"2013","unstructured":"Liu Y, Dai M, Bi Y, Xu M, Xu Y, Li M, et al. Active smoking, passive smoking, and risk of nonalcoholic fatty liver disease (NAFLD): a population-based study in China. J Epidemiol. 2013;23(2):115\u201321.","journal-title":"J Epidemiol"},{"issue":"1","key":"1922_CR57","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1097\/MEG.0b013e32832fcdf0","volume":"22","author":"L Caballeria","year":"2010","unstructured":"Caballeria L, Pera G, Auladell MA, Toran P, Munoz L, Miranda D, et al. Prevalence and factors associated with the presence of nonalcoholic fatty liver disease in an adult population in Spain. Eur J Gastroenterol Hepatol. 2010;22(1):24\u201332.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"8","key":"1922_CR58","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1111\/liv.13701","volume":"38","author":"NH Kim","year":"2018","unstructured":"Kim NH, Jung YS, Hong HP, Park JH, Kim HJ, Park DI, et al. Association between cotinine-verified smoking status and risk of nonalcoholic fatty liver disease. Liver Int. 2018;38(8):1487\u201394.","journal-title":"Liver Int"},{"issue":"4","key":"1922_CR59","doi-asserted-by":"publisher","first-page":"e0195147","DOI":"10.1371\/journal.pone.0195147","volume":"13","author":"M Okamoto","year":"2018","unstructured":"Okamoto M, Miyake T, Kitai K, Furukawa S, Yamamoto S, Senba H, et al. Cigarette smoking is a risk factor for the onset of fatty liver disease in nondrinkers: a longitudinal cohort study. PLoS ONE. 2018;13(4):e0195147.","journal-title":"PLoS ONE"},{"issue":"3","key":"1922_CR60","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/s41395-018-0283-5","volume":"114","author":"HS Jung","year":"2019","unstructured":"Jung HS, Chang Y, Kwon MJ, Sung E, Yun KE, Cho YK, et al. Smoking and the risk of non-alcoholic fatty liver disease: a cohort study. Am J Gastroenterol. 2019;114(3):453\u201363.","journal-title":"Am J Gastroenterol"},{"key":"1922_CR61","doi-asserted-by":"publisher","DOI":"10.3390\/cells14030221","author":"J Xu","year":"2025","unstructured":"Xu J, Li Y, Feng Z, Chen H. Cigarette smoke contributes to the progression of MASLD: from the molecular mechanisms to therapy. Cells. 2025. https:\/\/doi.org\/10.3390\/cells14030221.","journal-title":"Cells"},{"issue":"4","key":"1922_CR62","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jhep.2010.07.040","volume":"54","author":"CO Zein","year":"2011","unstructured":"Zein CO, Unalp A, Colvin R, Liu YC, McCullough AJ, Nonalcoholic Steatohepatitis Clinical Research N. Smoking and severity of hepatic fibrosis in nonalcoholic fatty liver disease. J Hepatol. 2011;54(4):753\u20139.","journal-title":"J Hepatol"},{"issue":"10","key":"1922_CR63","doi-asserted-by":"publisher","first-page":"e1912565","DOI":"10.1001\/jamanetworkopen.2019.12565","volume":"2","author":"DE Kleiner","year":"2019","unstructured":"Kleiner DE, Brunt EM, Wilson LA, Behling C, Guy C, Contos M, et al. Association of histologic disease activity with progression of nonalcoholic fatty liver disease. JAMA Netw Open. 2019;2(10):e1912565.","journal-title":"JAMA Netw Open"},{"issue":"8","key":"1922_CR64","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1080\/00365521.2017.1315169","volume":"52","author":"ID Munsterman","year":"2017","unstructured":"Munsterman ID, Smits MM, Andriessen R, van Nieuwkerk CMJ, Bloemena E, Mulder CJJ, et al. Smoking is associated with severity of liver fibrosis but not with histological severity in nonalcoholic fatty liver disease. Results from a cross-sectional study. Scand J Gastroenterol. 2017;52(8):881\u20135.","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"1922_CR65","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1007\/s00535-011-0376-z","volume":"46","author":"A Hamabe","year":"2011","unstructured":"Hamabe A, Uto H, Imamura Y, Kusano K, Mawatari S, Kumagai K, et al. Impact of cigarette smoking on onset of nonalcoholic fatty liver disease over a 10-year period. J Gastroenterol. 2011;46(6):769\u201378.","journal-title":"J Gastroenterol"},{"issue":"3","key":"1922_CR66","doi-asserted-by":"publisher","first-page":"H639","DOI":"10.1152\/ajpheart.00595.2018","volume":"316","author":"S Dikalov","year":"2019","unstructured":"Dikalov S, Itani H, Richmond B, Vergeade A, Rahman SMJ, Boutaud O, et al. Tobacco smoking induces cardiovascular mitochondrial oxidative stress, promotes endothelial dysfunction, and enhances hypertension. Am J Physiol Heart Circ Physiol. 2019;316(3):H639\u201346.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1922_CR67","doi-asserted-by":"publisher","first-page":"e13","DOI":"10.1017\/gmb.2024.3","volume":"5","author":"EE Imade","year":"2024","unstructured":"Imade EE, Obayagbona NO. Impact of cigarette smoking on gut microbial dysbiosis: a structured literature review. Gut Microbiome. 2024;5:e13.","journal-title":"Gut Microbiome"},{"key":"1922_CR68","first-page":"204800402513259","volume":"14","author":"IL Mladenova","year":"2025","unstructured":"Mladenova IL, Tan EF, Ng JY, Sharma P. Non-alcoholic fatty liver disease (NAFLD) and its association to cardiovascular disease: a comprehensive meta-analysis. JRSM Cardiovasc Dis. 2025;14:20480040251325930.","journal-title":"JRSM Cardiovasc Dis"},{"issue":"1","key":"1922_CR69","doi-asserted-by":"publisher","first-page":"24024","DOI":"10.1038\/s41598-024-74841-3","volume":"14","author":"X Wang","year":"2024","unstructured":"Wang X, You J, Tang J, Li X, Wang R, Li Y, et al. Interaction between non-alcoholic fatty liver disease and obesity on the risk of developing cardiovascular diseases. Sci Rep. 2024;14(1):24024.","journal-title":"Sci Rep"},{"issue":"3","key":"1922_CR70","doi-asserted-by":"publisher","first-page":"149","DOI":"10.3390\/metabo15030149","volume":"15","author":"V Padureanu","year":"2025","unstructured":"Padureanu V, Fortofoiu MC, Pirscoveanu M, Padureanu R, Radulescu D, Donoiu I, et al. Cardiovascular manifestations of patients with non-alcoholic fatty liver disease. Metabolites. 2025;15(3):149.","journal-title":"Metabolites"},{"key":"1922_CR71","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093336","author":"JJ Yoo","year":"2023","unstructured":"Yoo JJ, Park MY, Cho EJ, Yu SJ, Kim SG, Kim YJ, et al. Smoking increases the risk of hepatocellular carcinoma and cardiovascular disease in patients with metabolic-associated fatty liver disease. J Clin Med. 2023. https:\/\/doi.org\/10.3390\/jcm12093336.","journal-title":"J Clin Med"},{"issue":"5","key":"1922_CR72","doi-asserted-by":"publisher","first-page":"e24557","DOI":"10.1097\/MD.0000000000024557","volume":"100","author":"S Saokaew","year":"2021","unstructured":"Saokaew S, Kanchanasurakit S, Thawichai K, Duangprom P, Wannasri M, Khankham S, et al. Association of non-alcoholic fatty liver disease and all-cause mortality in hospitalized cardiovascular disease patients: a systematic review and meta-analysis. Medicine (Baltimore). 2021;100(5):e24557.","journal-title":"Medicine (Baltimore)"},{"issue":"42","key":"1922_CR73","doi-asserted-by":"publisher","first-page":"5334","DOI":"10.3748\/wjg.15.5334","volume":"15","author":"PH Chiang","year":"2009","unstructured":"Chiang PH, Chang TY, Chen JD. Synergistic effect of fatty liver and smoking on metabolic syndrome. World J Gastroenterol. 2009;15(42):5334\u20139.","journal-title":"World J Gastroenterol"},{"issue":"7","key":"1922_CR74","first-page":"826","volume":"19","author":"JH Lubin","year":"2017","unstructured":"Lubin JH, Couper D, Lutsey PL, Yatsuya H. Synergistic and non-synergistic associations for cigarette smoking and non-tobacco risk factors for cardiovascular disease incidence in the Atherosclerosis Risk In Communities (ARIC) study. Nicotine Tob Res. 2017;19(7):826\u201335.","journal-title":"Nicotine Tob Res"},{"issue":"6","key":"1922_CR75","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1136\/gutjnl-2017-313884","volume":"66","author":"LA Adams","year":"2017","unstructured":"Adams LA, Anstee QM, Tilg H, Targher G. Non-alcoholic fatty liver disease and its relationship with cardiovascular disease and other extrahepatic diseases. Gut. 2017;66(6):1138\u201353.","journal-title":"Gut"},{"issue":"3","key":"1922_CR76","first-page":"172","volume":"29","author":"RA Grucza","year":"2006","unstructured":"Grucza RA, Bierut LJ. Co-occurring risk factors for alcohol dependence and habitual smoking: update on findings from the Collaborative Study on the Genetics of Alcoholism. Alcohol Res Health. 2006;29(3):172\u20138.","journal-title":"Alcohol Res Health"},{"issue":"9","key":"1922_CR77","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1136\/gut.2008.162453","volume":"59","author":"J Altamirano","year":"2010","unstructured":"Altamirano J, Bataller R. Cigarette smoking and chronic liver diseases. Gut. 2010;59(9):1159\u201362.","journal-title":"Gut"},{"issue":"4","key":"1922_CR78","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.livres.2024.12.002","volume":"8","author":"HM Lin","year":"2024","unstructured":"Lin HM, Zhang JR, Li MX, Hou H, Wang H, Huang Y. Cigarette smoking and alcohol-related liver disease. Liver Res. 2024;8(4):237\u201345.","journal-title":"Liver Res"},{"issue":"1","key":"1922_CR79","doi-asserted-by":"publisher","first-page":"2037","DOI":"10.1186\/s12889-025-23184-3","volume":"25","author":"C Liu","year":"2025","unstructured":"Liu C, Shi T, Li S, Wu S, Chen J, Cai C, et al. Global, regional, and national liver cancer attributable to smoking and alcohol use burden, 1990\u20132021: analysis for the global burden of disease 2021 study. BMC Public Health. 2025;25(1):2037.","journal-title":"BMC Public Health"},{"key":"1922_CR80","doi-asserted-by":"publisher","first-page":"1427131","DOI":"10.3389\/fpubh.2024.1427131","volume":"12","author":"JJ Yoo","year":"2024","unstructured":"Yoo JJ, Lee DH, Kim SG, Jang JY, Kim YS, Kim LY. Impacts of smoking on alcoholic liver disease: a nationwide cohort study. Front Public Health. 2024;12:1427131.","journal-title":"Front Public Health"},{"issue":"5","key":"1922_CR81","doi-asserted-by":"publisher","first-page":"585","DOI":"10.3109\/00365521.2013.777469","volume":"48","author":"MK Dam","year":"2013","unstructured":"Dam MK, Flensborg-Madsen T, Eliasen M, Becker U, Tolstrup JS. Smoking and risk of liver cirrhosis: a population-based cohort study. Scand J Gastroenterol. 2013;48(5):585\u201391.","journal-title":"Scand J Gastroenterol"},{"issue":"10","key":"1922_CR82","doi-asserted-by":"publisher","first-page":"1248","DOI":"10.1093\/oxfordjournals.aje.a116433","volume":"136","author":"AL Klatsky","year":"1992","unstructured":"Klatsky AL, Armstrong MA. Alcohol, smoking, coffee, and cirrhosis. Am J Epidemiol. 1992;136(10):1248\u201357.","journal-title":"Am J Epidemiol"},{"issue":"6","key":"1922_CR83","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1007\/BF01719277","volume":"10","author":"G Corrao","year":"1994","unstructured":"Corrao G, Lepore AR, Torchio P, Valenti M, Galatola G, D\u2019Amicis A, et al. The effect of drinking coffee and smoking cigarettes on the risk of cirrhosis associated with alcohol consumption. A case-control study. Provincial Group for the Study of Chronic Liver Disease. Eur J Epidemiol. 1994;10(6):657\u201364.","journal-title":"Eur J Epidemiol"},{"issue":"7","key":"1922_CR84","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1001\/archinte.162.7.811","volume":"162","author":"CS Wang","year":"2002","unstructured":"Wang CS, Wang ST, Chang TT, Yao WJ, Chou P. Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression. Arch Intern Med. 2002;162(7):811\u20135.","journal-title":"Arch Intern Med"},{"issue":"2","key":"1922_CR85","doi-asserted-by":"publisher","first-page":"ofw050","DOI":"10.1093\/ofid\/ofw050","volume":"3","author":"CT Costiniuk","year":"2016","unstructured":"Costiniuk CT, Brunet L, Rollet-Kurhajec KC, Cooper CL, Walmsley SL, Gill MJ, et al. Tobacco smoking is not associated with accelerated liver disease in human immunodeficiency virus-hepatitis C coinfection: a longitudinal cohort analysis. Open Forum Infect Dis. 2016;3(2):ofw050.","journal-title":"Open Forum Infect Dis"},{"issue":"22","key":"1922_CR86","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1093\/jnci\/djr430","volume":"103","author":"M Sherman","year":"2011","unstructured":"Sherman M, Llovet JM. Smoking, hepatitis B virus infection, and development of hepatocellular carcinoma. J Natl Cancer Inst. 2011;103(22):1642\u20133.","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"1922_CR87","doi-asserted-by":"publisher","first-page":"15","DOI":"10.15403\/jgld.2014.1121.251.a2a","volume":"25","author":"T Zimmermann","year":"2016","unstructured":"Zimmermann T, Hueppe D, Mauss S, Buggisch P, Pfeiffer-Vornkahl H, Grimm D, et al. Effects of smoking on pegylated interferon alpha 2a and first generation protease inhibitor-based antiviral therapy in naive patients infected with hepatitis C virus genotype 1. J Gastrointestin Liver Dis. 2016;25(1):15\u201324.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"20","key":"1922_CR88","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.3748\/wjg.v10.i20.2963","volume":"10","author":"A El-Zayadi","year":"2004","unstructured":"El-Zayadi A, Selim O, Hamdy H, El-Tawil A, Badran HM, Attia M, et al. Impact of cigarette smoking on response to interferon therapy in chronic hepatitis C Egyptian patients. World J Gastroenterol. 2004;10(20):2963\u20136.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"1922_CR89","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1080\/00365520902803515","volume":"44","author":"E Tsochatzis","year":"2009","unstructured":"Tsochatzis E, Papatheodoridis GV, Manolakopoulos S, Tiniakos DG, Manesis EK, Archimandritis AJ. Smoking is associated with steatosis and severe fibrosis in chronic hepatitis C but not B. Scand J Gastroenterol. 2009;44(6):752\u20139.","journal-title":"Scand J Gastroenterol"},{"issue":"1","key":"1922_CR90","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1053\/jhep.2001.25385","volume":"34","author":"F Pessione","year":"2001","unstructured":"Pessione F, Ramond MJ, Njapoum C, Duchatelle V, Degott C, Erlinger S, et al. Cigarette smoking and hepatic lesions in patients with chronic hepatitis C. Hepatology. 2001;34(1):121\u20135.","journal-title":"Hepatology"},{"key":"1922_CR91","doi-asserted-by":"publisher","first-page":"197","DOI":"10.15403\/jgld-181","volume":"28","author":"K Wijarnpreecha","year":"2019","unstructured":"Wijarnpreecha K, Werlang M, Panjawatanan P, Kroner PT, Mousa OY, Pungpapong S, et al. Association between smoking and risk of primary biliary cholangitis: a systematic review and meta-analysis. J Gastrointestin Liver Dis. 2019;28:197\u2013203.","journal-title":"J Gastrointestin Liver Dis"},{"issue":"6","key":"1922_CR92","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1111\/j.1872-034X.2011.00806.x","volume":"41","author":"Y Liang","year":"2011","unstructured":"Liang Y, Yang Z, Zhong R. Smoking, family history and urinary tract infection are associated with primary biliary cirrhosis: a meta-analysis. Hepatol Res. 2011;41(6):572\u20138.","journal-title":"Hepatol Res"},{"issue":"2","key":"1922_CR93","doi-asserted-by":"publisher","first-page":"313","DOI":"10.3904\/kjim.2019.234","volume":"36","author":"KA Kim","year":"2021","unstructured":"Kim KA, Kim YS, Park SH, Chung WJ, Choi DH, Jang ES, et al. Environmental risk factors and comorbidities of primary biliary cholangitis in Korea: a case-control study. Korean J Intern Med. 2021;36(2):313\u201321.","journal-title":"Korean J Intern Med"},{"issue":"1","key":"1922_CR94","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s00535-021-01836-6","volume":"57","author":"K Matsumoto","year":"2022","unstructured":"Matsumoto K, Ohfuji S, Abe M, Komori A, Takahashi A, Fujii H, et al. Environmental factors, medical and family history, and comorbidities associated with primary biliary cholangitis in Japan: a multicenter case-control study. J Gastroenterol. 2022;57(1):19\u201329.","journal-title":"J Gastroenterol"},{"issue":"6","key":"1922_CR95","doi-asserted-by":"publisher","first-page":"806","DOI":"10.4103\/ijmr.IJMR_639_19","volume":"154","author":"K Wijarnpreecha","year":"2021","unstructured":"Wijarnpreecha K, Werlang M, Panjawatanan P, Pungpapong S, Lukens FJ, Harnois DM, et al. Smoking & risk of advanced liver fibrosis among patients with primary biliary cholangitis: a systematic review & meta-analysis. Indian J Med Res. 2021;154(6):806\u201312.","journal-title":"Indian J Med Res"},{"issue":"2","key":"1922_CR96","doi-asserted-by":"publisher","first-page":"101251","DOI":"10.1016\/j.jhepr.2024.101251","volume":"7","author":"J Lim","year":"2025","unstructured":"Lim J, Kim YJ, Kim S, Choi J. Risk of hepatocellular carcinoma in Asian patients with primary biliary cholangitis: a nationwide and hospital cohort study. JHEP Rep. 2025;7(2):101251.","journal-title":"JHEP Rep"},{"issue":"3","key":"1922_CR97","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u201363.","journal-title":"CA Cancer J Clin"},{"key":"1922_CR98","doi-asserted-by":"publisher","first-page":"5905357","DOI":"10.1155\/2021\/5905357","volume":"2021","author":"D Jain","year":"2021","unstructured":"Jain D, Chaudhary P, Varshney N, Bin Razzak KS, Verma D, Khan Zahra TR, et al. Tobacco smoking and liver cancer risk: potential avenues for carcinogenesis. J Oncol. 2021;2021:5905357.","journal-title":"J Oncol"},{"issue":"3","key":"1922_CR99","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.amjms.2023.11.016","volume":"367","author":"M Li","year":"2024","unstructured":"Li M, Sun J, Wang Y, Ma J, Hao X, Liu Y, et al. Construction of a hepatocellular carcinoma high-risk population rating scale and independent predictors\u2019 assessment. Am J Med Sci. 2024;367(3):181\u20139.","journal-title":"Am J Med Sci"},{"key":"1922_CR100","first-page":"1","volume":"85","author":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans","year":"2004","unstructured":"IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Betel-quid and areca-nut chewing and some areca-nut derived nitrosamines. IARC Monogr Eval Carcinog Risks Hum. 2004;85:1\u2013334.","journal-title":"IARC Monogr Eval Carcinog Risks Hum"},{"issue":"6","key":"1922_CR101","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1093\/ije\/dyp280","volume":"38","author":"YC Lee","year":"2009","unstructured":"Lee YC, Cohet C, Yang YC, Stayner L, Hashibe M, Straif K. Meta-analysis of epidemiologic studies on cigarette smoking and liver cancer. Int J Epidemiol. 2009;38(6):1497\u2013511.","journal-title":"Int J Epidemiol"},{"issue":"5","key":"1922_CR102","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1158\/1055-9965.EPI-09-1297","volume":"19","author":"SC Chuang","year":"2010","unstructured":"Chuang SC, Lee YC, Hashibe M, Dai M, Zheng T, Boffetta P. Interaction between cigarette smoking and hepatitis B and C virus infection on the risk of liver cancer: a meta-analysis. Cancer Epidemiol Biomarkers Prev. 2010;19(5):1261\u20138.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"2","key":"1922_CR103","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1016\/j.jhep.2004.10.005","volume":"42","author":"JA Marrero","year":"2005","unstructured":"Marrero JA, Fontana RJ, Fu S, Conjeevaram HS, Su GL, Lok AS. Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinoma. J Hepatol. 2005;42(2):218\u201324.","journal-title":"J Hepatol"},{"issue":"4","key":"1922_CR104","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1002\/ijc.35401","volume":"157","author":"EK Aglago","year":"2025","unstructured":"Aglago EK, Ramos I, Keski-Rahkonen P, Chatziioannou C, Freisling H, Fedirko V, et al. Alcohol and smoking habits in association with hepatocellular carcinoma risk. Int J Cancer. 2025;157(4):644\u201357.","journal-title":"Int J Cancer"},{"issue":"2","key":"1922_CR105","doi-asserted-by":"publisher","first-page":"253","DOI":"10.17998\/jlc.2024.06.02","volume":"24","author":"J Lee","year":"2024","unstructured":"Lee J, Choi JY, Lee SK. Heavy smoking increases early mortality risk in patients with hepatocellular carcinoma after curative treatment. J Liver Cancer. 2024;24(2):253\u201362.","journal-title":"J Liver Cancer"},{"issue":"4","key":"1922_CR106","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/jebm.12270","volume":"10","author":"O Abdel-Rahman","year":"2017","unstructured":"Abdel-Rahman O, Helbling D, Schob O, Eltobgy M, Mohamed H, Schmidt J, et al. Cigarette smoking as a risk factor for the development of and mortality from hepatocellular carcinoma: an updated systematic review of 81 epidemiological studies. J Evid Based Med. 2017;10(4):245\u201354.","journal-title":"J Evid Based Med"},{"issue":"8","key":"1922_CR107","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1002\/lt.21471","volume":"14","author":"JA Leithead","year":"2008","unstructured":"Leithead JA, Ferguson JW, Hayes PC. Smoking-related morbidity and mortality following liver transplantation. Liver Transpl. 2008;14(8):1159\u201364.","journal-title":"Liver Transpl"},{"issue":"7","key":"1922_CR108","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1053\/jlts.2002.34150","volume":"8","author":"S Pungpapong","year":"2002","unstructured":"Pungpapong S, Manzarbeitia C, Ortiz J, Reich DJ, Araya V, Rothstein KD, et al. Cigarette smoking is associated with an increased incidence of vascular complications after liver transplantation. Liver Transpl. 2002;8(7):582\u20137.","journal-title":"Liver Transpl"},{"issue":"7","key":"1922_CR109","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.oraloncology.2005.03.014","volume":"41","author":"C Scheifele","year":"2005","unstructured":"Scheifele C, Reichart PA, Hippler-Benscheidt M, Neuhaus P, Neuhaus R. Incidence of oral, pharyngeal, and laryngeal squamous cell carcinomas among 1515 patients after liver transplantation. Oral Oncol. 2005;41(7):670\u20136.","journal-title":"Oral Oncol"},{"issue":"1","key":"1922_CR110","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.critrevonc.2004.12.011","volume":"56","author":"GH Vallejo","year":"2005","unstructured":"Vallejo GH, Romero CJ, de Vicente JC. Incidence and risk factors for cancer after liver transplantation. Crit Rev Oncol Hematol. 2005;56(1):87\u201399.","journal-title":"Crit Rev Oncol Hematol"},{"issue":"2","key":"1922_CR111","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0210-5705(03)79044-X","volume":"26","author":"MV Catalina","year":"2003","unstructured":"Catalina MV, de Diego A, Garcia-Sanchez A, Escudero M, Salcedo M, Banares R, et al. [Characterization of de novo malignancies in liver transplantation]. Gastroenterol Hepatol. 2003;26(2):57\u201363.","journal-title":"Gastroenterol Hepatol"},{"issue":"5","key":"1922_CR112","doi-asserted-by":"publisher","first-page":"1896","DOI":"10.1016\/S0041-1345(03)00645-6","volume":"35","author":"E Rubio","year":"2003","unstructured":"Rubio E, Moreno JM, Turrion VS, Jimenez M, Lucena JL, Cuervas-Mons V. De novo malignancies and liver transplantation. Transplant Proc. 2003;35(5):1896\u20137.","journal-title":"Transplant Proc"},{"issue":"3","key":"1922_CR113","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/LVT.0000000000000485","volume":"31","author":"CR Cecil","year":"2025","unstructured":"Cecil CR, Moutchia J, Krowka MJ, Dubrock HM, Forde KA, Krok KL, et al. Smoking and outcomes in candidates for liver transplantation: analysis of the Pulmonary Vascular Complications of Liver Disease 2 (PVCLD2). Liver Transpl. 2025;31(3):323\u201332.","journal-title":"Liver Transpl"},{"issue":"1","key":"1922_CR114","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1111\/j.1432-2277.2010.01146.x","volume":"24","author":"AK Mathur","year":"2011","unstructured":"Mathur AK, Ranney DN, Patel SP, Lee DS, Bednar F, Lynch RJ, et al. The effect of smoking on biliary complications following liver transplantation. Transpl Int. 2011;24(1):58\u201366.","journal-title":"Transpl Int"},{"issue":"2","key":"1922_CR115","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bpg.2017.03.005","volume":"31","author":"J Ursic-Bedoya","year":"2017","unstructured":"Ursic-Bedoya J, Donnadieu-Rigole H, Faure S, Pageaux GP. Alcohol use and smoking after liver transplantation; complications and prevention. Best Pract Res Clin Gastroenterol. 2017;31(2):181\u20135.","journal-title":"Best Pract Res Clin Gastroenterol"},{"issue":"6","key":"1922_CR116","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1002\/lt.21722","volume":"15","author":"F van der Heide","year":"2009","unstructured":"van der Heide F, Dijkstra G, Porte RJ, Kleibeuker JH, Haagsma EB. Smoking behavior in liver transplant recipients. Liver Transpl. 2009;15(6):648\u201355.","journal-title":"Liver Transpl"},{"key":"1922_CR117","first-page":"100528","volume":"23","author":"E Boakye","year":"2023","unstructured":"Boakye E, Erhabor J, Obisesan O, Tasdighi E, Mirbolouk M, Osuji N, et al. Comprehensive review of the national surveys that assess E-cigarette use domains among youth and adults in the United States. Lancet Reg Health. 2023;23:100528.","journal-title":"Lancet Reg Health"},{"issue":"16","key":"1922_CR118","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1097\/CM9.0000000000003098","volume":"137","author":"X Li","year":"2024","unstructured":"Li X, Yuan L, Wang F. Health outcomes of electronic cigarettes. Chin Med J (Engl). 2024;137(16):1903\u201311.","journal-title":"Chin Med J (Engl)"},{"key":"1922_CR119","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/j.toxrep.2022.06.006","volume":"9","author":"M Esteban-Lopez","year":"2022","unstructured":"Esteban-Lopez M, Perry MD, Garbinski LD, Manevski M, Andre M, Ceyhan Y, et al. Health effects and known pathology associated with the use of E-cigarettes. Toxicol Rep. 2022;9:1357\u201368.","journal-title":"Toxicol Rep"},{"key":"1922_CR120","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines13081998","author":"I Jukic","year":"2025","unstructured":"Jukic I, Matulic I, Vukovic J. Effects of nicotine-free e-cigarettes on gastrointestinal system: a systematic review. Biomedicines. 2025. https:\/\/doi.org\/10.3390\/biomedicines13081998.","journal-title":"Biomedicines"},{"issue":"2","key":"1922_CR121","doi-asserted-by":"publisher","first-page":"e15146","DOI":"10.14814\/phy2.15146","volume":"10","author":"A Lechasseur","year":"2022","unstructured":"Lechasseur A, Mouchiroud M, Tremblay F, Bouffard G, Milad N, Pineault M, et al. Glycerol contained in vaping liquids affects the liver and aspects of energy homeostasis in a sex-dependent manner. Physiol Rep. 2022;10(2):e15146.","journal-title":"Physiol Rep"},{"key":"1922_CR122","doi-asserted-by":"publisher","DOI":"10.3390\/jox15020053","author":"L Manietta","year":"2025","unstructured":"Manietta L, Drake W, Jayawardene W. Comparative analysis of inflammatory and heavy metal biomarkers in exclusive E-cigarette users, combustible tobacco users, and non-users aged 18\u201330: a cross-sectional NHANES analysis. J Xenobiotics. 2025. https:\/\/doi.org\/10.3390\/jox15020053.","journal-title":"J Xenobiotics"},{"issue":"8","key":"1922_CR123","doi-asserted-by":"publisher","first-page":"430","DOI":"10.5694\/mja2.51481","volume":"216","author":"A Larcombe","year":"2022","unstructured":"Larcombe A, Allard S, Mullins B. Chemical analysis of fresh and aged Australian e-cigarette liquids. Med J Aust. 2022;216(8):430.","journal-title":"Med J Aust"},{"key":"1922_CR124","doi-asserted-by":"publisher","first-page":"153964","DOI":"10.1016\/j.tox.2024.153964","volume":"509","author":"A Guraka","year":"2024","unstructured":"Guraka A, Mierlea S, Drake SJ, Shawa IT, Waldron J, Corcoran M, et al. A comprehensive toxicological analysis of panel of unregulated e-cigarettes to human health. Toxicology. 2024;509:153964.","journal-title":"Toxicology"},{"issue":"6","key":"1922_CR125","doi-asserted-by":"publisher","first-page":"e0457","DOI":"10.1097\/HC9.0000000000000457","volume":"8","author":"T Mihara","year":"2024","unstructured":"Mihara T, Hori M. Nicotine aggravates liver fibrosis via alpha7 nicotinic acetylcholine receptor expressed on activated hepatic stellate cells in mice. Hepatol Commun. 2024;8(6):e0457.","journal-title":"Hepatol Commun"},{"issue":"3","key":"1922_CR126","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1124\/dmd.123.001348","volume":"52","author":"K Kanamori","year":"2024","unstructured":"Kanamori K, Ahmad SM, Hamid A, Lutfy K. Chronic exposure to e-cigarettes elevates CYP2A5 activity, protein expression, and cotinine-induced production of reactive oxygen species in mice. Drug Metab Dispos. 2024;52(3):171\u20139.","journal-title":"Drug Metab Dispos"},{"key":"1922_CR127","doi-asserted-by":"publisher","unstructured":"Mears MJ, Bandaru P, Neczypor EW, Byun MK, Zhang M, Gorr MW, et al. Multisystem toxicity of E-cigarettes in preclinical and clinical studies: Pathophysiologic effects of E-cigarette aerosol exposures from head to toe. Annu Rev Pharmacol Toxicol. 2025; https:\/\/doi.org\/10.1146\/annurev-pharmtox-062124-022856.","DOI":"10.1146\/annurev-pharmtox-062124-022856"},{"key":"1922_CR128","doi-asserted-by":"publisher","DOI":"10.3390\/antiox13111395","author":"A Magna","year":"2024","unstructured":"Magna A, Polisena N, Polisena L, Bagnato C, Pacella E, Carnevale R, et al. The hidden dangers: e-cigarettes, heated tobacco, and their impact on oxidative stress and atherosclerosis-a systematic review and narrative synthesis of the evidence. Antioxidants. 2024. https:\/\/doi.org\/10.3390\/antiox13111395.","journal-title":"Antioxidants"},{"issue":"6","key":"1922_CR129","doi-asserted-by":"publisher","first-page":"2442","DOI":"10.1002\/hep.30512","volume":"69","author":"KM Hasan","year":"2019","unstructured":"Hasan KM, Friedman TC, Shao X, Parveen M, Sims C, Lee DL, et al. E-cigarettes and Western diet: important metabolic risk factors for hepatic diseases. Hepatology. 2019;69(6):2442\u201354.","journal-title":"Hepatology"},{"key":"1922_CR130","doi-asserted-by":"publisher","first-page":"1525166","DOI":"10.3389\/fimmu.2025.1525166","volume":"16","author":"E Wawryk-Gawda","year":"2025","unstructured":"Wawryk-Gawda E, Zarobkiewicz MK, Wolanin-Stachyra M, Opoka-Winiarska V. Inflammatory markers activation associated with vapor or smoke exposure in Wistar rats. Front Immunol. 2025;16:1525166.","journal-title":"Front Immunol"},{"key":"1922_CR131","doi-asserted-by":"publisher","first-page":"320","DOI":"10.3389\/fendo.2019.00320","volume":"10","author":"J Espinoza-Derout","year":"2019","unstructured":"Espinoza-Derout J, Shao XM, Bankole E, Hasan KM, Mtume N, Liu Y, et al. Hepatic DNA damage induced by electronic cigarette exposure is associated with the modulation of NAD+\/PARP1\/SIRT1 axis. Front Endocrinol (Lausanne). 2019;10:320.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"3","key":"1922_CR132","doi-asserted-by":"publisher","first-page":"222","DOI":"10.4103\/atm.atm_59_24","volume":"19","author":"HM Al-Otaibi","year":"2024","unstructured":"Al-Otaibi HM, Baqasi AM, Alhadrami HA. Genotoxicity and mutagenicity assessment of electronic cigarette liquids. Ann Thorac Med. 2024;19(3):222\u20137.","journal-title":"Ann Thorac Med"},{"key":"1922_CR133","doi-asserted-by":"publisher","first-page":"755124","DOI":"10.3389\/fphys.2021.755124","volume":"12","author":"H Chen","year":"2021","unstructured":"Chen H, Li G, Chan YL, Zhang HE, Gorrell MD, Pollock CA, et al. Differential effects of \u201cvaping\u201d on lipid and glucose profiles and liver metabolic markers in obese versus non-obese mice. Front Physiol. 2021;12:755124.","journal-title":"Front Physiol"},{"issue":"Pt A","key":"1922_CR134","doi-asserted-by":"publisher","first-page":"113067","DOI":"10.1016\/j.intimp.2024.113067","volume":"142","author":"Y Wei","year":"2024","unstructured":"Wei Y, Pan T, Zhao Y, Chen Z, Wu L, Fang S, et al. Nicotine aggravates high-fat diet-induced non-alcoholic fatty liver disease in mice via inhibition of CISD3. Int Immunopharmacol. 2024;142(Pt A):113067.","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"1922_CR135","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1111\/nyas.14411","volume":"1475","author":"G Li","year":"2020","unstructured":"Li G, Chan YL, Wang B, Saad S, George J, Oliver BG, et al. E-cigarettes damage the liver and alter nutrient metabolism in pregnant mice and their offspring. Ann N Y Acad Sci. 2020;1475(1):64\u201377.","journal-title":"Ann N Y Acad Sci"},{"key":"1922_CR136","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.annepidem.2023.05.009","volume":"85","author":"J Cai","year":"2023","unstructured":"Cai J, Bidulescu A. Associations between e-cigarette use or dual use of e-cigarette and combustible cigarette and metabolic syndrome: results from the National Health and Nutrition Examination Survey (NHANES). Ann Epidemiol. 2023;85:93-99 e2.","journal-title":"Ann Epidemiol"},{"key":"1922_CR137","doi-asserted-by":"publisher","first-page":"110948","DOI":"10.1016\/j.drugalcdep.2023.110948","volume":"251","author":"J Cai","year":"2023","unstructured":"Cai J, Bidulescu A. The association between e-cigarette use or dual use of e-cigarette and combustible cigarette and prediabetes, diabetes, or insulin resistance: findings from the National Health and Nutrition Examination Survey (NHANES). Drug Alcohol Depend. 2023;251:110948.","journal-title":"Drug Alcohol Depend"},{"key":"1922_CR138","doi-asserted-by":"publisher","first-page":"1973","DOI":"10.2147\/COPD.S524978","volume":"20","author":"CY Kim","year":"2025","unstructured":"Kim CY, Park SH, Seong Y, Choi YJ, Park HJ, Cho JH, et al. Dual Use of electronic cigarettes and cigarettes elevates risk of chronic obstructive pulmonary disease and mental health issues: insights from a Korean Health Survey. Int J Chron Obstruct Pulmon Dis. 2025;20:1973\u201381.","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"issue":"1","key":"1922_CR139","first-page":"13","volume":"3","author":"S Assari","year":"2024","unstructured":"Assari S, Sheikhattari P. Social epidemiology of dual use of electronic and combustible cigarettes among U.S. adults: insights from the population assessment of tobacco and health (PATH) study. Glob J Cardiovasc Dis. 2024;3(1):13\u201323.","journal-title":"Glob J Cardiovasc Dis"},{"key":"1922_CR140","doi-asserted-by":"publisher","first-page":"31","DOI":"10.18332\/tid\/159167","volume":"21","author":"M Han","year":"2023","unstructured":"Han M, Jeong S, Song J, Park SJ, Min Lee C, Lee K, et al. Association between the dual use of electronic and conventional cigarettes and NAFLD status in Korean men. Tob Induc Dis. 2023;21:31.","journal-title":"Tob Induc Dis"},{"issue":"4","key":"1922_CR141","doi-asserted-by":"publisher","first-page":"e0320573","DOI":"10.1371\/journal.pone.0320573","volume":"20","author":"Z Li","year":"2025","unstructured":"Li Z, Guo H, He H, Wang S, Pei S, Xie L. The relationship between smoking cessation history and significant liver fibrosis among the population with metabolic dysfunction-associated steatotic liver disease in the United States. PLoS ONE. 2025;20(4):e0320573.","journal-title":"PLoS ONE"},{"issue":"12","key":"1922_CR142","doi-asserted-by":"publisher","first-page":"e074216","DOI":"10.1136\/bmjopen-2023-074216","volume":"13","author":"S Zhang","year":"2023","unstructured":"Zhang S, Liu Z, Yang Q, Hu Z, Zhou W, Ji G, et al. Impact of smoking cessation on non-alcoholic fatty liver disease prevalence: a systematic review and meta-analysis. BMJ Open. 2023;13(12):e074216.","journal-title":"BMJ Open"},{"issue":"1","key":"1922_CR143","doi-asserted-by":"publisher","first-page":"10300","DOI":"10.1038\/s41598-023-37194-x","volume":"13","author":"S Han","year":"2023","unstructured":"Han S, Jeong S, Ahn JC, Cho Y, Choi S, Park SJ, et al. Association of post-smoking cessation changes in fasting serum glucose with changes in predicted fatty liver score. Sci Rep. 2023;13(1):10300.","journal-title":"Sci Rep"},{"issue":"1","key":"1922_CR144","doi-asserted-by":"publisher","first-page":"150","DOI":"10.5009\/gnl220038","volume":"17","author":"S Jeong","year":"2023","unstructured":"Jeong S, Oh YH, Choi S, Chang J, Kim SM, Park SJ, et al. Association of change in smoking status and subsequent weight change with risk of nonalcoholic fatty liver disease. Gut Liver. 2023;17(1):150\u20138.","journal-title":"Gut Liver"},{"issue":"8","key":"1922_CR145","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/ntr\/ntae032","volume":"26","author":"JF Cohen","year":"2024","unstructured":"Cohen JF, Ward KM, Gittleman J, Perez E, Pia T, Shuter J, et al. Hepatitis C and cigarette smoking behavior: themes from focus groups. Nicotine Tob Res. 2024;26(8):1029\u201337.","journal-title":"Nicotine Tob Res"},{"issue":"1","key":"1922_CR146","doi-asserted-by":"publisher","first-page":"124","DOI":"10.3892\/etm.2011.351","volume":"3","author":"AB Siegel","year":"2012","unstructured":"Siegel AB, Conner K, Wang S, Jacobson JS, Hershman DL, Hidalgo R, et al. Smoking and hepatocellular carcinoma mortality. Exp Ther Med. 2012;3(1):124\u20138.","journal-title":"Exp Ther Med"},{"issue":"5","key":"1922_CR147","doi-asserted-by":"publisher","first-page":"e0178570","DOI":"10.1371\/journal.pone.0178570","volume":"12","author":"Q Li","year":"2017","unstructured":"Li Q, Wang Y, Ma T, Liu X, Wang B, Wu Z, et al. Impact of cigarette smoking on early complications after liver transplantation: a single-center experience and a meta-analysis. PLoS ONE. 2017;12(5):e0178570.","journal-title":"PLoS ONE"},{"issue":"2","key":"1922_CR148","doi-asserted-by":"publisher","first-page":"636","DOI":"10.1016\/j.transproceed.2021.01.033","volume":"53","author":"MA Wahab","year":"2021","unstructured":"Wahab MA, Abdel-Khalek EE, Elshoubary M, Yassen AM, Salah T, Sultan AM, et al. Predictive factors of de novo malignancies after living-donor liver transplantation: a single-center experience. Transplant Proc. 2021;53(2):636\u201344.","journal-title":"Transplant Proc"},{"issue":"12","key":"1922_CR149","doi-asserted-by":"publisher","first-page":"533","DOI":"10.4254\/wjh.v8.i12.533","volume":"8","author":"PK Mukthinuthalapati","year":"2016","unstructured":"Mukthinuthalapati PK, Gotur R, Ghabril M. Incidence, risk factors and outcomes of de novo malignancies post liver transplantation. World J Hepatol. 2016;8(12):533\u201344.","journal-title":"World J Hepatol"},{"issue":"1","key":"1922_CR150","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1053\/j.semtcvs.2018.02.033","volume":"30","author":"MA Steliga","year":"2018","unstructured":"Steliga MA. Smoking cessation in clinical practice: how to get patients to stop. Semin Thorac Cardiovasc Surg. 2018;30(1):87\u201391.","journal-title":"Semin Thorac Cardiovasc Surg"},{"issue":"6","key":"1922_CR151","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1111\/liv.14807","volume":"41","author":"P Iruzubieta","year":"2021","unstructured":"Iruzubieta P, Arias-Loste MT, Fortea JI, Cuadrado A, Rivas-Rivas C, Rodriguez-Duque JC, et al. National digestive disease specialists survey on cardiovascular risk management in non-alcoholic fatty liver disease in Spanish hospitals. Liver Int. 2021;41(6):1243\u201353.","journal-title":"Liver Int"},{"issue":"1","key":"1922_CR152","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1038\/s41598-019-57369-9","volume":"10","author":"N Yoshioka","year":"2020","unstructured":"Yoshioka N, Ishigami M, Watanabe Y, Sumi H, Doisaki M, Yamaguchi T, et al. Effect of weight change and lifestyle modifications on the development or remission of nonalcoholic fatty liver disease: sex-specific analysis. Sci Rep. 2020;10(1):481.","journal-title":"Sci Rep"},{"key":"1922_CR153","doi-asserted-by":"publisher","first-page":"108206","DOI":"10.1016\/j.pec.2024.108206","volume":"123","author":"FC Wei","year":"2024","unstructured":"Wei FC, Huang CH, Huang CY, Tsai YP, Jeng C. Effectiveness of health education and counseling on stages of change, decisional balance, and smoking cessation self-efficacy: a prospective self-control study. Patient Educ Couns. 2024;123:108206.","journal-title":"Patient Educ Couns"},{"issue":"5","key":"1922_CR154","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1001\/jamainternmed.2024.8399","volume":"185","author":"ER Park","year":"2025","unstructured":"Park ER, Haas JS, Rigotti NA, Neil JM, Marotta CJ, Wint AJ, et al. Integrating tobacco treatment into lung cancer screening: the screen assist factorial randomized clinical trial. JAMA Intern Med. 2025;185(5):531\u20139.","journal-title":"JAMA Intern Med"},{"issue":"2","key":"1922_CR155","first-page":"e54051","volume":"16","author":"J Thakur","year":"2024","unstructured":"Thakur J, Choudhari SG. Effectiveness of healthcare interventions on smoking cessation in adolescents in low- and middle-income countries: a narrative review. Cureus. 2024;16(2):e54051.","journal-title":"Cureus"}],"container-title":["Clinical and Experimental Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01922-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10238-025-01922-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10238-025-01922-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T06:02:23Z","timestamp":1764741743000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10238-025-01922-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,3]]},"references-count":155,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["1922"],"URL":"https:\/\/doi.org\/10.1007\/s10238-025-01922-6","relation":{},"ISSN":["1591-9528"],"issn-type":[{"value":"1591-9528","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,3]]},"assertion":[{"value":"18 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable. This manuscript is a review article and does not involve a research protocol requiring approval by the relevant institutional review board or ethics committee.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"51"}}